| Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases J Peña‐Guerrero, PA Nguewa, AT García‐Sosa Wiley Interdisciplinary Reviews: Computational Molecular Science 11 (5), e1513, 2021 | 33 | 2021 |
| Leishmanicidal activity of isoselenocyanate derivatives C Fernández-Rubio, E Larrea, J Peña Guerrero, E Sesma Herrero, ... Antimicrobial agents and chemotherapy 63 (2), 10.1128/aac. 00904-18, 2019 | 32 | 2019 |
| Discovery and validation of Lmj_04_BRCT domain, a novel therapeutic target: Identification of candidate drugs for leishmaniasis J Peña-Guerrero, C Fernández-Rubio, A Burguete-Mikeo, R El-Dirany, ... International Journal of Molecular Sciences 22 (19), 10493, 2021 | 12 | 2021 |
| LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome A Vacas, C Fernández-Rubio, E Larrea, J Peña-Guerrero, PA Nguewa Biomedicines 8 (11), 452, 2020 | 12 | 2020 |
| The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major May Be Involved in the Resistance to Drugs such as Paromomycin A Vacas, C Fernández-Rubio, M Algarabel, J Peña-Guerrero, E Larrea, ... Biomolecules 9 (11), 723, 2019 | 11 | 2019 |
| Construction of Two mCherry Plasmids (pXG-mCherry) for Transgenic Leishmania: Valuable Tools for Future Molecular Analysis A Vacas, C Sugden, Ó Velasco-Rodriguez, M Algarabel-Olona, ... Journal of parasitology research 2017, 2017 | 10 | 2017 |
| Repurposing the antibacterial agents peptide 19-4LF and Peptide 19-2.5 for treatment of cutaneous leishmaniasis R El-Dirany, C Fernández-Rubio, J Peña-Guerrero, E Moreno, E Larrea, ... Pharmaceutics 14 (11), 2528, 2022 | 8 | 2022 |
| In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity M Algarabel, C Fernández-Rubio, K Musilova, J Peña-Guerrero, A Vacas, ... International Journal of Molecular Sciences 22 (22), 12592, 2021 | 7 | 2021 |
| BRCT Domains: Structure, Functions, and Implications in Disease—New Therapeutic Targets for Innovative Drug Discovery against Infections J Peña-Guerrero, C Fernández-Rubio, AT García-Sosa, PA Nguewa Pharmaceutics 15 (7), 1839, 2023 | 3 | 2023 |
| The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells E Larrea, C Fernández-Rubio, J Peña-Guerrero, E Guruceaga, ... International Journal of Molecular Sciences 23 (21), 13203, 2022 | 2 | 2022 |
| Improving the miltefosine efficacy against leishmaniasis by using different nanoassemblies made from surfactants or amphiphilic antimony (V) complex J Peña-Guerrero, J Puig-Rigall, G González-Gaitano, P Nguewa Applications of Nanobiotechnology for Neglected Tropical Diseases, 253-290, 2021 | 2 | 2021 |
| Characterization of Leishmania Parasites Isolated from Naturally Infected Mammals A Burguete-Mikeo, C Fernández-Rubio, J Peña-Guerrero, R El-Dirany, ... Animals 13 (13), 2153, 2023 | 1 | 2023 |
| OVEREXPRESSION OF THE KINASE JEAN3 FROM LEISHMANIA MAJOR MAY ATTENUATE PARASITES INFECTIVITY IN BALB/C MICE BY IMPAIRING THE TH2-TYPE IMMUNE RESPONSE THROUGH THE DOWNREGULATION … A Vacas, C Fernandez-Rubio, E Larrea, J Pena-Guerrero, M Algarabel, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 101, 171-171, 2019 | | 2019 |
| Nguewa., et al.“Function and Stage-Regulated Expression of the LmcDNA16 Gene Family Related to Leishmania Infectivity in Mammals” A Paul EC Veterinary Science 4, 175-179, 2019 | | 2019 |
| STUDY OF A NEWLY DISCOVERED ONCOGENIC DOMAIN OF YINP FROM LEISHMANIA SP. J Pena-Guerrero, M Algarabel-Olona, C Fernandez-Rubio, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 99 (4), 176-177, 2018 | | 2018 |
| Research Article Construction of Two mCherry Plasmids (pXG-mCherry) for Transgenic Leishmania: Valuable Tools for Future Molecular Analysis M Algarabel-Olona, J Peña-Guerrero, E Larrea, C Fernández-Rubio, ... | | 2017 |
